New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 19, 2014
08:36 EDTANGOAngioDynamics upgraded at Canaccord
As reported previously, Canaccord upgraded AngioDynamics to Buy from Hold based on improving business trends and strong cash generation, which the firm sees driving growth over the next few years. Canaccord raised its price target on the stock to $20 from $16.25.
News For ANGO From The Last 14 Days
Check below for free stories on ANGO the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for ANGO

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use